ADVFN US – Market Content Editor

  • U.S. Home Prices Slip for Third Month in a Row in July

    U.S. Home Prices Slip for Third Month in a Row in July

    U.S. housing prices fell by 0.1% in July on a seasonally adjusted basis, marking the third consecutive month of declines, according to a new report from real estate firm Redfin (NASDAQ:RDFN). Annual price growth slowed to 2.9%, the weakest pace recorded since Redfin began compiling its Redfin Home Price Index (RHPI) in 2012. The RHPI,…

  • U.S. Residential Construction Surges Unexpectedly in July

    U.S. Residential Construction Surges Unexpectedly in July

    Data released Tuesday by the Commerce Department revealed a surprising uptick in new residential construction across the United States in July. According to the report, housing starts jumped 5.2% to a seasonally adjusted annual rate of 1.428 million units, following a revised 5.9% increase in June that brought the total to 1.358 million. Economists had…

  • Dow Jones, S&P, Nasdaq, Wall Street Futures, Volatile Trading Expected Ahead of Fed Minutes and Powell Speech

    Dow Jones, S&P, Nasdaq, Wall Street Futures, Volatile Trading Expected Ahead of Fed Minutes and Powell Speech

    U.S. stock futures indicate a mostly flat start on Tuesday, suggesting that markets may continue the muted performance seen in Monday’s session. Investors are likely to remain cautious ahead of several significant economic events later this week, including the release of the Federal Reserve’s latest policy meeting minutes on Wednesday and the start of the…

  • Tesla’s Robotaxi Trial in Austin Shows Strong Pricing Edge, Says William Blair

    Tesla’s Robotaxi Trial in Austin Shows Strong Pricing Edge, Says William Blair

    Tesla (NASDAQ:TSLA) offered a glimpse of its autonomous future with a robotaxi trial in Austin, showcasing both competitive pricing and a human-like driving experience, according to William Blair. The firm said the demonstration, held ahead of the public rollout in September, highlighted Tesla’s potential to gain market share using cost-efficient autonomous technology. “Robotaxi was half…

  • Novo Nordisk’s Ozempic Secures Canadian Approval for Kidney Disease Use

    Novo Nordisk’s Ozempic Secures Canadian Approval for Kidney Disease Use

    Novo Nordisk (NYSE:NVO) said Tuesday that Health Canada has expanded the label for its diabetes therapy Ozempic, granting approval for use in patients with chronic kidney disease. The new indication allows physicians to prescribe Ozempic to help slow the progression of kidney impairment, reduce the risk of kidney failure, and lower the likelihood of cardiovascular-related…

  • Peabody Energy Shares Surge After Canceling Anglo American Acquisition

    Peabody Energy Shares Surge After Canceling Anglo American Acquisition

    Peabody Energy (NYSE:BTU) climbed 9% after the coal company announced it is walking away from its planned purchase of Anglo American Plc’s (LSE:AAL) steelmaking coal operations, citing a material adverse change. The move follows nearly five months of uncertainty tied to a March 31 ignition incident at Anglo’s Moranbah North Mine, where there is still…

  • Black Hills Shares Decline Following Merger Agreement With NorthWestern Energy

    Black Hills Shares Decline Following Merger Agreement With NorthWestern Energy

    Black Hills Corp. (NYSE:BKH) dropped 3.6% to $58.20 in Tuesday’s premarket session after unveiling an all-stock merger with NorthWestern Energy Group (NASDAQ:NWE). The transaction, approved unanimously by both companies’ boards, will form a regulated utility player with a combined market capitalization of about $7.8 billion and an enterprise value of $15.4 billion. NorthWestern shares, which…

  • TEGNA Shares Gain After Nexstar Unveils $6.2 Billion Acquisition Plan

    TEGNA Shares Gain After Nexstar Unveils $6.2 Billion Acquisition Plan

    TEGNA Inc. (NYSE:TGNA) stock climbed 2.8% on Tuesday after Nexstar Media Group (NASDAQ:NXST) announced it would acquire the broadcaster in a $6.2 billion all-cash deal. The agreement values TEGNA at $22 per share, a 31% premium over the company’s 30-day average stock price ending August 8, 2025. TEGNA’s board has unanimously approved the transaction, which…

  • Opera Stock Climbs as Q2 Results Top Forecasts, Outlook Raised

    Opera Stock Climbs as Q2 Results Top Forecasts, Outlook Raised

    Opera Limited (NASDAQ:OPRA) saw its shares gain nearly 3% in pre-market trading on Tuesday after the browser and AI-driven services company reported second-quarter results that came in ahead of Wall Street expectations and lifted its full-year guidance. Adjusted earnings per share came in at $0.26, well above analyst projections of $0.20. Revenue surged 30% year-over-year…

  • Viking Therapeutics Plunges 37% on Obesity Drug Trial Concerns

    Viking Therapeutics Plunges 37% on Obesity Drug Trial Concerns

    Shares of Viking Therapeutics (NASDAQ:VKTX) tumbled as much as 37% on Tuesday after the company released data from its Phase 2 VENTURE-Oral Dosing trial for its experimental oral obesity treatment. In contrast, Eli Lilly (NYSE:LLY) stock gained 1.5% as analysts emphasized the strength of its competing therapies. The trial results showed that Viking’s oral formulation…